CH581113A5 - - Google Patents

Info

Publication number
CH581113A5
CH581113A5 CH1430773A CH1430773A CH581113A5 CH 581113 A5 CH581113 A5 CH 581113A5 CH 1430773 A CH1430773 A CH 1430773A CH 1430773 A CH1430773 A CH 1430773A CH 581113 A5 CH581113 A5 CH 581113A5
Authority
CH
Switzerland
Application number
CH1430773A
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to CH1430773A priority Critical patent/CH581113A5/xx
Priority to SE7412310A priority patent/SE7412310L/xx
Priority to DK514874AA priority patent/DK135766B/da
Priority to NO743534A priority patent/NO743534L/no
Priority to FI2863/74A priority patent/FI286374A/fi
Priority to GB4290974A priority patent/GB1474775A/en
Priority to NL7413105A priority patent/NL7413105A/xx
Priority to DD181520A priority patent/DD114605A5/xx
Priority to IL45797A priority patent/IL45797A/xx
Priority to PH16382A priority patent/PH11611A/en
Priority to DE19742447756 priority patent/DE2447756A1/de
Priority to BE149290A priority patent/BE820789A/xx
Priority to ES430759A priority patent/ES430759A1/es
Priority to CA210,857A priority patent/CA1021772A/en
Priority to AT802974A priority patent/ATA802974A/de
Priority to JP49114815A priority patent/JPS5082078A/ja
Priority to HUSA2697A priority patent/HU169126B/hu
Priority to AU74089/74A priority patent/AU488997B2/en
Priority to SU7402066522A priority patent/SU567403A3/ru
Priority to FR7433761A priority patent/FR2247242B1/fr
Priority to ZA00746409A priority patent/ZA746409B/xx
Priority to AU74090/74A priority patent/AU498889B2/en
Priority to AU74130/74A priority patent/AU7413074A/en
Priority to US05/664,968 priority patent/US4073909A/en
Publication of CH581113A5 publication Critical patent/CH581113A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1430773A 1973-10-08 1973-10-08 CH581113A5 (US06291489-20010918-C00077.png)

Priority Applications (24)

Application Number Priority Date Filing Date Title
CH1430773A CH581113A5 (US06291489-20010918-C00077.png) 1973-10-08 1973-10-08
SE7412310A SE7412310L (US06291489-20010918-C00077.png) 1973-10-08 1974-09-30
DK514874AA DK135766B (da) 1973-10-08 1974-09-30 Analogifremgangsmåde til fremstilling af isoquinoliner.
NO743534A NO743534L (US06291489-20010918-C00077.png) 1973-10-08 1974-09-30
FI2863/74A FI286374A (US06291489-20010918-C00077.png) 1973-10-08 1974-10-01
GB4290974A GB1474775A (en) 1973-10-08 1974-10-03 Isoquinolines
NL7413105A NL7413105A (nl) 1973-10-08 1974-10-04 Werkwijze ter bereiding van nieuwe heterocycli- verbindingen.
DD181520A DD114605A5 (US06291489-20010918-C00077.png) 1973-10-08 1974-10-04
IL45797A IL45797A (en) 1973-10-08 1974-10-07 Isoquinoline derivatives their production and pharmaceutical compositions containing them
PH16382A PH11611A (en) 1973-10-08 1974-10-07 1-(3-amino-2-hydroxypropoxy)isoquinoline derivatives and pharmaceutical compositions thereof
DE19742447756 DE2447756A1 (de) 1973-10-08 1974-10-07 Verfahren zur herstellung neuer heterocyclischer verbindungen
BE149290A BE820789A (fr) 1973-10-08 1974-10-07 Nouveaux derives de l'isoquinoleine
ES430759A ES430759A1 (es) 1973-10-08 1974-10-07 Procedimiento para preparar derivados de isoquinolina.
CA210,857A CA1021772A (en) 1973-10-08 1974-10-07 1-aminopropoxy-isoquinoline
AT802974A ATA802974A (de) 1973-10-08 1974-10-07 Verfahren zur herstellung von neuen isochinolinderivaten und ihren salzen
JP49114815A JPS5082078A (US06291489-20010918-C00077.png) 1973-10-08 1974-10-07
HUSA2697A HU169126B (US06291489-20010918-C00077.png) 1973-10-08 1974-10-08
AU74089/74A AU488997B2 (en) 1973-10-08 1974-10-08 Improvements in or relating to isoquinoline derivatives
SU7402066522A SU567403A3 (ru) 1973-10-08 1974-10-08 Способ получени производных изохинолина или их солей
FR7433761A FR2247242B1 (US06291489-20010918-C00077.png) 1973-10-08 1974-10-08
ZA00746409A ZA746409B (en) 1973-10-08 1974-10-08 Improvements in or relating to organic compounds
AU74090/74A AU498889B2 (en) 1973-10-08 1974-10-08 Piperidylene benzocycloheptathiophenes
AU74130/74A AU7413074A (en) 1973-10-08 1974-10-09 Triglycidyl compounds
US05/664,968 US4073909A (en) 1973-10-08 1976-03-08 Isoquinoline compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1430773A CH581113A5 (US06291489-20010918-C00077.png) 1973-10-08 1973-10-08

Publications (1)

Publication Number Publication Date
CH581113A5 true CH581113A5 (US06291489-20010918-C00077.png) 1976-10-29

Family

ID=4399720

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1430773A CH581113A5 (US06291489-20010918-C00077.png) 1973-10-08 1973-10-08

Country Status (21)

Country Link
JP (1) JPS5082078A (US06291489-20010918-C00077.png)
AT (1) ATA802974A (US06291489-20010918-C00077.png)
AU (2) AU498889B2 (US06291489-20010918-C00077.png)
BE (1) BE820789A (US06291489-20010918-C00077.png)
CA (1) CA1021772A (US06291489-20010918-C00077.png)
CH (1) CH581113A5 (US06291489-20010918-C00077.png)
DD (1) DD114605A5 (US06291489-20010918-C00077.png)
DE (1) DE2447756A1 (US06291489-20010918-C00077.png)
DK (1) DK135766B (US06291489-20010918-C00077.png)
ES (1) ES430759A1 (US06291489-20010918-C00077.png)
FI (1) FI286374A (US06291489-20010918-C00077.png)
FR (1) FR2247242B1 (US06291489-20010918-C00077.png)
GB (1) GB1474775A (US06291489-20010918-C00077.png)
HU (1) HU169126B (US06291489-20010918-C00077.png)
IL (1) IL45797A (US06291489-20010918-C00077.png)
NL (1) NL7413105A (US06291489-20010918-C00077.png)
NO (1) NO743534L (US06291489-20010918-C00077.png)
PH (1) PH11611A (US06291489-20010918-C00077.png)
SE (1) SE7412310L (US06291489-20010918-C00077.png)
SU (1) SU567403A3 (US06291489-20010918-C00077.png)
ZA (1) ZA746409B (US06291489-20010918-C00077.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7603371L (sv) * 1975-03-26 1976-09-27 Sandoz Ag Organiska foreningar, deras anvendning och framstellning
US4129565A (en) * 1975-07-11 1978-12-12 Nisshin Flour Milling Co., Ltd. Isocarbostyril derivatives
DK166478A (da) * 1977-05-02 1978-11-03 Merck & Co Inc Fremgangsmaade til fremstilling af naphthyridiner
EP0711804A3 (de) 1994-11-14 1999-09-22 Ciba SC Holding AG Kryptolichtschutzmittel
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6197785B1 (en) 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
WO2001090077A1 (en) 2000-05-19 2001-11-29 Guilford Pharmaceuticals, Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout

Also Published As

Publication number Publication date
AU7413074A (en) 1976-04-15
AU7409074A (en) 1976-04-15
CA1021772A (en) 1977-11-29
HU169126B (US06291489-20010918-C00077.png) 1976-09-28
FR2247242B1 (US06291489-20010918-C00077.png) 1978-07-21
FI286374A (US06291489-20010918-C00077.png) 1975-04-09
SE7412310L (US06291489-20010918-C00077.png) 1975-04-09
DK135766C (US06291489-20010918-C00077.png) 1977-11-21
FR2247242A1 (US06291489-20010918-C00077.png) 1975-05-09
ZA746409B (en) 1976-05-26
NO743534L (US06291489-20010918-C00077.png) 1975-05-05
AU7408974A (en) 1976-04-15
DD114605A5 (US06291489-20010918-C00077.png) 1975-08-12
AU498889B2 (en) 1979-03-29
DE2447756A1 (de) 1975-04-10
BE820789A (fr) 1975-04-07
PH11611A (en) 1978-04-12
SU567403A3 (ru) 1977-07-30
NL7413105A (nl) 1975-04-10
ES430759A1 (es) 1977-04-16
IL45797A0 (en) 1974-12-31
IL45797A (en) 1978-04-30
DK514874A (US06291489-20010918-C00077.png) 1975-06-09
GB1474775A (en) 1977-05-25
JPS5082078A (US06291489-20010918-C00077.png) 1975-07-03
DK135766B (da) 1977-06-20
ATA802974A (de) 1979-07-15

Similar Documents

Publication Publication Date Title
AR201758A1 (US06291489-20010918-C00077.png)
AU476761B2 (US06291489-20010918-C00077.png)
AU465372B2 (US06291489-20010918-C00077.png)
AR201235Q (US06291489-20010918-C00077.png)
AR201231Q (US06291489-20010918-C00077.png)
AU474593B2 (US06291489-20010918-C00077.png)
AU474511B2 (US06291489-20010918-C00077.png)
AU474838B2 (US06291489-20010918-C00077.png)
AU471343B2 (US06291489-20010918-C00077.png)
AU465453B2 (US06291489-20010918-C00077.png)
AU465434B2 (US06291489-20010918-C00077.png)
AU450229B2 (US06291489-20010918-C00077.png)
AU476714B2 (US06291489-20010918-C00077.png)
AR201229Q (US06291489-20010918-C00077.png)
AU466283B2 (US06291489-20010918-C00077.png)
AU476696B2 (US06291489-20010918-C00077.png)
AU472848B2 (US06291489-20010918-C00077.png)
AR199451A1 (US06291489-20010918-C00077.png)
AU477823B2 (US06291489-20010918-C00077.png)
AU461342B2 (US06291489-20010918-C00077.png)
AU471461B2 (US06291489-20010918-C00077.png)
AR200256A1 (US06291489-20010918-C00077.png)
AU476873B1 (US06291489-20010918-C00077.png)
AR210729A1 (US06291489-20010918-C00077.png)
AU477824B2 (US06291489-20010918-C00077.png)

Legal Events

Date Code Title Description
PL Patent ceased